Menu

Immunotherapy

Dr Morganna Freeman outlines some of the criteria used in deciding which patients will most benefit from immunotherapy.
Dr Morganna Freeman discusses some of the ways immunotherapy has changed cancer care, including the expectation for long-term survival and how to treat patients in remission.
Dr Morganna Freeman considers the future application of treatment modalities and how they might be combined for optimal results.
Dr Morganna Freeman on the challenge of deciding when to treat a patient with immunotherapy.
Dr Morganna Freeman breaks down her methods for explaining immunotherapy to her patients.

Results 1 - 5 of 5

Thank you to our Corporate Sponsors and Alliance Partners!

  • National Alliance Partner

    National Alliance Partner

  • National Alliance Partner

    National Alliance Partner

  • National Healthcare SystemAlliance Partner

    National Healthcare System
    Alliance Partner

  • National Healthcare SystemAlliance Partner

    National Healthcare System
    Alliance Partner

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Silver Corporate Sponsor

    Silver Corporate Sponsor

  • Cornerstone Corporate Sponsor

    Cornerstone Corporate Sponsor

  • Industry Relations Council Alliance Sponsor

    Industry Relations
    Council Alliance Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations
    Council Member